Home › Leverkanker (hepatocellulair carcinoom) › Californië › Los Angeles
Leverkanker (hepatocellulair carcinoom) klinische studies in Los Angeles, CA
19 studies voor Leverkanker (hepatocellulair carcinoom) zoeken deelnemers op locaties in en rond Los Angeles (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
RekruterenFase 1/2
- START Los Angeles, LLC, Los Angeles
- Keck Hospital of USC, Los Angeles
- Los Angeles General Medical Center, Los Angeles
- en nog 3
National Liver Cancer Screening Trial
RekruterenFase 4
- University of Southern California, Los Angeles
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
RekruterenFase 1/2
- Local Institution - 0070, Los Angeles
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
RekruterenFase 1
- USC Norris Comprehensive Cancer Center, Los Angeles
Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure
RekruterenFase 2
- USC Norris Comprehensive Cancer Center, Los Angeles
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
RekruterenObservatieonderzoek
- Cedars-Sinai Medical Center, Los Angeles
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
RekruterenFase 3
- Research Site, Los Angeles
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
RekruterenFase 1
- University of Southern California, Los Angeles
- Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer, Los Angeles
- Cedars-Sanai Medical Center, Los Angeles
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RekruterenFase 1/2
- Children's Hospital Los Angeles, Los Angeles
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekruterenFase 1/2
- University of California, Los Angeles (UCLA), Los Angeles
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
RekruterenFase 1/2
- Research Site, Los Angeles
A Study of MGC026 in Participants With Advanced Solid Tumors
RekruterenFase 1
- The Angeles Clinic and Research Institute, Los Angeles
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
RekruterenFase 1/2
- Los Angeles Cancer Network, Los Angeles
ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma
RekruterenFase 1/2
- Children's Hospital Los Angeles, Los Angeles
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
RekruterenFase 1
- Clinical Trial Site, Los Angeles
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
RekruterenFase 2
- USA06-0, Los Angeles
- USA16-0, Los Angeles
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
RekruterenFase 1/2
- Norris Comprehensive Cancer Center, Los Angeles
Multilevel Determinants of Socioeconomic Disparities in Geographic Late-Stage Hepatocellular Carcinoma Hotspots
RekruterenObservatieonderzoek
- USC / Norris Comprehensive Cancer Center, Los Angeles
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
RekruterenFase 1/2
- Research Site 125, Los Angeles
- Research Site 133, Los Angeles
- Research Site 103, Los Angeles
Leverkanker (hepatocellulair carcinoom) studies in andere steden
- Houston, TX31 studies
- New York City, NY24 studies
- Dallas, TX19 studies
- Boston, MA18 studies
- Cleveland, OH18 studies
- Chicago, IL16 studies
- Philadelphia, PA16 studies
- Pittsburgh, PA15 studies
- San Francisco, CA14 studies
- Orange, CA14 studies
- Jacksonville, FL14 studies
- San Antonio, TX13 studies
Andere studies in Los Angeles
- Niet-kleincellige longkanker87 studies
- Kanker (alle vormen)74 studies
- Borstkanker73 studies
- Prostaatkanker61 studies
- Colorectale kanker59 studies
- Metastatische kanker57 studies
- Eierstokkanker50 studies
- Longkanker45 studies
- Plaveiselcelcarcinoom van hoofd en hals42 studies
- Aldermeesklierkanker35 studies
- Endometriumkanker34 studies
- Melanoom34 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.